載入...
Importance of immunopharmacogenomics in cancer treatment: Patient selection and monitoring for immune checkpoint antibodies
In the last 5 years, immune checkpoint antibodies have become established as anticancer agents for various types of cancer. These antibody drugs, namely cytotoxic T‐lymphocyte‐associated antigen, programmed death‐1, and programmed death ligand‐1 antibodies, have revealed relatively high response rat...
Na minha lista:
| 發表在: | Cancer Sci |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4768396/ https://ncbi.nlm.nih.gov/pubmed/26678880 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12862 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|